← Leaderboards
Mahendra Kumar
University Of Miami Coral Gables
$16,032,799
Attributed
$18,572,521
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$18,572,521 · 8
By mechanism
R01$17,927,999 · 7
P01$644,522 · 1
Top collaborators
- Varan Govind5 shared
- Deborah Lynne Jones5 shared
Most similar at University Of Miami Coral Gables
Same institution · by research overlap
- Michael Howard Antoni$15,681,390
- Philip M McCabe$4,921,907
- Shigui Ruan$1,399,330
- Roger Christopher McIntosh$2,717,400
- Suzanne C Lechner$3,044,207
Others in their field
Top investigators on “Neuroendocrine System”
- Carol D. Ryff · University Of Wisconsin Madison$35,205,842
- Joseph S Takahashi · University Of Chicago$29,093,863
- J. Mark Cline · Wake Forest University$20,130,326
- Eric Ravussin · Lsu Pennington Biomedical Research Ctr$13,398,243
- Thomas F Martin · University Of Wisconsin Madison$12,462,397
- Richard H. Goodman · Oregon Health And Science University$12,187,566
Research focus
Neuroendocrine SystemHiv InfectionsHormone Regulation /Control MechanismInfectionParticipantReportingClinical ResearchHuman SubjectHiv-1Thyroid GlandWomanCocaineInvestigationInflammatoryIndiaComorbidityRisk FactorsAdrenocorticotropic HormoneIntravenous Drug AbuseHuman Immunodeficiency Virus 1Pathologic ProcessDrug AbuserCytokineGenetic
Grant awards (40)
MRSI and DKI Evaluation of HIV-1 Clade C Infection in the Whole Brain$401,473
R01 · FY2020 · NS
MRSI and DKI Evaluation of HIV-1 Clade C Infection in the Whole Brain$457,469
R01 · FY2019 · NS
Predictive Biomarkers of CVD Risk in Diverse HIV-1+ Cocaine Abusers$464,823
R01 · FY2018 · DA · contact PI
MRSI and DKI Evaluation of HIV-1 Clade C Infection in the Whole Brain$456,902
R01 · FY2018 · NS
Predictive Biomarkers of CVD Risk in Diverse HIV-1+ Cocaine Abusers$478,258
R01 · FY2017 · DA · contact PI
MRSI and DKI Evaluation of HIV-1 Clade C Infection in the Whole Brain$456,352
R01 · FY2017 · NS
Predictive Biomarkers of CVD Risk in Diverse HIV-1+ Cocaine Abusers$614,529
R01 · FY2016 · DA · contact PI
MRSI and DKI Evaluation of HIV-1 Clade C Infection in the Whole Brain$481,798
R01 · FY2016 · NS
Predictive Biomarkers of CVD Risk in Diverse HIV-1+ Cocaine Abusers$621,873
R01 · FY2015 · DA · contact PI
HIV-1 Infection in Methamphetamine Abusers: Endocrine Outcomes$570,942
R01 · FY2015 · DA · contact PI
Predictive Biomarkers of CVD Risk in Diverse HIV-1+ Cocaine Abusers$645,968
R01 · FY2014 · DA · contact PI
HIV-1 Infection in Methamphetamine Abusers: Endocrine Outcomes$594,875
R01 · FY2014 · DA · contact PI
HIV-1 Infection in Methamphetamine Abusers: Endocrine Outcomes$572,711
R01 · FY2013 · DA · contact PI
HIV-1 Infection in Methamphetamine Abusers: Endocrine Outcomes$598,311
R01 · FY2012 · DA · contact PI
HIV-1 Infection in Methamphetamine Abusers: Endocrine Outcomes$602,777
R01 · FY2011 · DA · contact PI
HIV-1 C Clade Progression and NeuroAIDS$480,097
R01 · FY2010 · NS · contact PI
HIV-1 C Clade Progression and NeuroAIDS$477,196
R01 · FY2009 · NS · contact PI
HIV-1 C Clade Progression and NeuroAIDS$474,491
R01 · FY2008 · NS · contact PI
HIV-1 C Clade Progression and NeuroAIDS$480,517
R01 · FY2007 · NS · contact PI
HIV-1 C Clade Progression and NeuroAIDS$500,756
R01 · FY2006 · NS · contact PI
HIV1 + IDU's--ENDOCRINE CONSEQUENCES &MEDICAL OUTCOMES$645,088
R01 · FY2005 · DA
HIV-1 &HIV-2 CO-INFECTI0N: NEUROLOGICAL PROGRESSION$489,799
R01 · FY2005 · NS
HIV1 + IDU's--ENDOCRINE CONSEQUENCES &MEDICAL OUTCOMES$752,274
R01 · FY2004 · DA
HIV-1 &HIV-2 CO-INFECTI0N: NEUROLOGICAL PROGRESSION$476,725
R01 · FY2004 · NS
HIV1 + IDU's--ENDOCRINE CONSEQUENCES &MEDICAL OUTCOMES$719,416
R01 · FY2003 · DA
HIV-1 &HIV-2 CO-INFECTI0N: NEUROLOGICAL PROGRESSION$462,805
R01 · FY2003 · NS
IDU'S HIV-1 INFECTION, NEUROENDOCRINE RESPONSES$447,014
R01 · FY2003 · DA
HIV1 + IDU's--ENDOCRINE CONSEQUENCES &MEDICAL OUTCOMES$87,815
R01 · FY2003 · DA
HIV1 + IDU's--ENDOCRINE CONSEQUENCES &MEDICAL OUTCOMES$561,456
R01 · FY2002 · DA
HIV-1 &HIV-2 CO-INFECTI0N: NEUROLOGICAL PROGRESSION$454,502
R01 · FY2002 · NS
IDU'S HIV-1 INFECTION, NEUROENDOCRINE RESPONSES$436,418
R01 · FY2002 · DA
CORE--ENDOCRINOLOGY$124,146
P01 · FY2002 · MH
CORE--ENDOCRINOLOGY$124,146
P01 · FY2002 · MH
HIV1 + IDU's--ENDOCRINE CONSEQUENCES &MEDICAL OUTCOMES$94,371
R01 · FY2002 · DA
HIV1 + IDU's--ENDOCRINE CONSEQUENCES &MEDICAL OUTCOMES$579,678
R01 · FY2001 · DA
HIV-1/HIV-2 CO-INFECTI0N: NEUROLOGICAL PROGRESSION$446,249
R01 · FY2001 · NS
IDU'S HIV-1 INFECTION, NEUROENDOCRINE RESPONSES$426,129
R01 · FY2001 · DA
CORE--ENDOCRINOLOGY$124,146
P01 · FY2001 · MH
IDU'S HIV-1 INFECTION, NEUROENDOCRINE RESPONSES$416,142
R01 · FY2000 · DA
CORE--ENDOCRINOLOGY$272,084
P01 · FY2000 · MH